Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis

被引:1
|
作者
Stamuli, Eugena [1 ]
Corry, Sorcha [2 ]
Foss, Petter [2 ]
机构
[1] Pharmecons Easy Access Ltd, York, England
[2] Novartis Oncol Reg Europe, Origgio, Italy
关键词
Breast cancer; discrete choice experiment; trade-offs; latent class; Europe; RELATIVE EFFECTIVENESS ASSESSMENTS; CLINICAL BENEFIT; DECISION-MAKING; LOGIT-MODELS; HEALTH; QUALITY; COMMAND; MAGNITUDE; SURVIVAL; SOCIETY;
D O I
10.1017/S0266462323000168
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ObjectivesThe evolution of breast cancer (BC) treatments has resulted in tailored therapies for the different types and stages of BC. Each treatment has a profile of benefits and adverse effects which are taken into consideration when planning a treatment pathway. This study examines whether patients' preferences are in line with what is considered important from decision makers viewpoint. MethodsAn online discrete choice experiment was conducted in six European countries (France, Germany, Ireland, Poland, Spain, UK) with BC patients. Six attributes were included: overall survival (OS), hyperglycemia, rash, pain, functional well-being (FWB), and out-of-pocket payment (OOP). Sixteen choice sets with two hypothetical treatments and a "No treatment" option were presented. Data were analyzed with the use of heteroscedastic conditional, mixed logistic, and latent class models. Marginal rate of substitution (MRS) were estimated for OOP versus the rest of attributes to establish the ranking of preferences for each attribute. ResultsTwo hundred and forty-seven patients with advanced or metastatic BC and 314 with early-stage BC responded. Forty-nine percent of patients were < 44 years old and 65 percent had completed university education. The MRS of the analysis demonstrated that "severe pain" is the highest dis-preferred attribute level, followed by "severe impairment in FWB" and OS. Four classes of patients as "decision makers" were identified. ConclusionsThis study suggests that there is heterogeneity in treatment preferences of BC patients depending on their sociodemographic and disease-related characteristics. In combination with clinical guidelines, patient preferences can support the selection and tailoring of treatment options.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] PATIENT PREFERENCES DO MATTER: A DISCRETE CHOICE EXPERIMENT (DCE) CONDUCTED WITH BREAST CANCER PATIENTS IN SIX EUROPEAN COUNTRIES
    Stamuli, E.
    Corry, S.
    Hatzikou, M.
    Foss, P.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S239 - S239
  • [2] Patient preferences for breast cancer treatments: A discrete choice experiment from four European countries
    Konstantopoulou, T.
    Stamuli, E.
    Ross, D.
    Pacheco, R.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [3] Patient Preferences for Attributes of Androgen Deprivation Therapies in Prostate Cancer: A Discrete Choice Experiment with Latent Class Analysis
    Hauber, Brett
    Hong, Agnes
    Hunsche, Elke
    Maculaitis, Martine C.
    Collins, Sean P.
    [J]. ADVANCES IN THERAPY, 2024, 41 (10) : 3934 - 3950
  • [4] Do Patient Preferences Align With Value Frameworks? A Discrete-Choice Experiment of Patients With Breast Cancer
    Hollin, Ilene L.
    Gonzalez, Juan Marcos
    Buelt, Lisabeth
    Ciarametaro, Michael
    Dubois, Robert W.
    [J]. MDM POLICY & PRACTICE, 2020, 5 (01)
  • [5] PATIENTS' PREFERENCES FOR BREAST CANCER TREATMENTS: SUBGROUP ANALYSIS RESULTS FROM DISCRETE CHOICE EXPERIMENT (DCE) SURVEY IN 4 EUROPEAN COUNTRIES
    Konstantopoulou, Thomais
    Stamuli, Eugena
    Pacheco, Ricardo Gaminha
    [J]. BREAST, 2019, 48 : S37 - S37
  • [6] ARE PATIENTS' PREFERENCES FOR OSTEOPOROSIS DRUG TREATMENT TRANSFERABLE BETWEEN COUNTRIES? RESULTS FROM A DISCRETE-CHOICE EXPERIMENT CONDUCTED IN TWO EUROPEAN COUNTRIES
    Hiligsmann, M.
    Dellaert, B.
    Dirksen, C.
    Van der Weijden, T.
    Goemaere, S.
    McGowan, B.
    Reginster, J. Y.
    Watson, V
    Boonen, A.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A568 - A569
  • [7] Patient preferences for oncoplastic breast surgery in early breast cancer: A discrete choice experiment
    Gonen, N.
    Menke, M.
    De Bekker-Grob, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 57 : S26 - S26
  • [8] Breast and Colorectal Cancer Patients' Preferences for Pharmacogenomics: A Discrete Choice Experiment
    Issa, Amalia M.
    Tufail, Waqas
    Ajike, Roseline
    Tenorio, Jose
    McKeever, John
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S328 - S328
  • [9] Preferences for Pharmacist Counselling in Patients with Breast Cancer: A Discrete Choice Experiment
    Kawaguchi, Takashi
    Azuma, Kanako
    Yamaguchi, Takuhiro
    Iwase, Satoru
    Matsunaga, Tadaharu
    Yamada, Kimito
    Miyamatsu, Hironobu
    Takeuchi, Hironori
    Kohno, Norio
    Akashi, Takao
    Unezaki, Sakae
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (11) : 1795 - 1802
  • [10] Patients' preferences for breast reconstruction: A discrete choice experiment
    Damen, Tim H. C.
    de Bekker-Grob, Esther W.
    Mureau, Marc A. M.
    Menke-Pluijmers, Marian B.
    Seynaeve, Caroline
    Hofer, Stefan O. P.
    Essink-Bot, Marie-Louise
    [J]. JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2011, 64 (01): : 75 - 83